Home Patent Forecast® Sectors Sign In   Sign Up   Support   Contact  
Why Patent Forecast® What's Included Patent Forecast® Sectors Free Trial Pricing News Feed Subscribe Menu

MedReleaf’s Second Cannabis Cultivar Patent Application

Cannabis Patent Forecast®

May 21, 2020

MedReleaf, wholly-owned subsidiary of Aurora Cannabis, has applied for a second Cannabis sativa cultivar plant patent (US Pub. No. 20200154623) named ‘MR2018003’. 

New cannabis cultivar ‘MR2018003’ is the result of selection from a controlled-cross between the female Cannabis sativa variety `Pakistan Chitral Kush Landrace` and the male Cannabis sativa variety `UK Cheese`. 

‘MR2018003’ is characterized as having 16% THC, 0% CBD, and significant resistance to microbial growth, as compared to progeny of the same lineage. The cannabis cultivar ‘Girl Scout Cookies’ is mentioned as the closest cannabis cultivar to the new ‘MR2018003’, but ‘MR2018003’ can be distinguished from ‘Girl Scout Cookies’ by its increased resistance to microbial growth. Plant diseases can cause losses in unimaginable numbers, so having plants with higher resistance to microbial growth is extremely desirable.   

MedReleaf’s portfolio now consists of 5 cannabis patents and patent applications categorized under Magic Number’s Cannabis Patent Forecast® as  ‘Compositions - Topical’, ‘Cultivation - Cultivar’, and ‘Processing - Extraction’. Take a closer look at MedReleaf’s, along with dozens of others’, IP portfolios, neatly categorized and displayed, with a subscription to Magic Number

green cannabis plant close-up photography

Relevant Patent Documents

Application 20200154623  

Article Source Link

MedReleaf


View Patent Forecast®

Cannabis is now legally being used to treat a wide variety of medical conditions, including chronic pain, alcoholism, anxiety, nausea (from chemotherapy) and epilepsy. Additionally, the fact that it is a botanical means that there is room for development in plant cultivation and processing, besides the traditional pharma areas of drug synthesis, formulation, processing and delivery.

Cannabis   Patent Forecast®

View Patent Forecast® Top Corporations News and Insights Data Visualization

Cannabis is now legally being used to treat a wide variety of medical conditions, including chronic pain, alcoholism, anxiety, nausea (from chemotherapy) and epilepsy. Additionally, the fact that it is a botanical means that there is room for development in plant cultivation and processing, besides the traditional pharma areas of drug synthesis, formulation, processing and delivery.